Pioglitazone is a thiazolidinedione that improves insulin sensitivity in peripheral tissues and the liver. It works by activating PPAR-γ receptors, promoting glucose uptake without stimulating insulin secretion. Pioglitazone is used in type 2 diabetes, often in combination with other antidiabetic agents when monotherapy is insufficient.